این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Basic and Clinical Cancer Research، جلد ۶، شماره ۲، صفحات ۱۰-۱۵
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Assessment of Selective Growth Inhibitory Effects of HESA-A on Some Human Neoplastic Cell Lines
چکیده انگلیسی مقاله Background: During the past few years, HESA-A, a herbal-marine mixture, has been used to treat cancer as an alternative medicine in Iran. However, weight of the evidence is not sufficient to accept or refuse the use of this compound as a cytotoxic drug. We investigated the selective anticancer effects of HESA-A on breast, prostate, colon, and glioblastoma multiforme (GBM) neoplastic cell lines. Methods: MTT-based cytotoxicity assay was performed on HCT-116 (colon adenocarcinoma), MCF-7 (breast adenocarcinoma), PC-3 (prostate adenocarcinoma), U-87MG (GBM), and HDF-1 (normal dermal fibroblast) cell lines using different concentrations of HESA-A (0, 1, 3.3, 10, 33 and 100 µg/ml) and doxorubicin as positive control (10 µM). If there was seen an inhibitory response, median inhibitory concentration (IC 50 ) was determined. We defined the cytotoxicity as the extrapolated IC 50 became equal to or lower than 50 µg/ml. Results: HESA-A at the highest concentration (100 µg/mL) significantly inhibited the growth of HCT-116 cell line (P = 0.003; compared to control) .Percentage growth inhibition of HESA-A at this concentration was determined as 40.13%. IC 50 of this compound on HCT-116 cell line was extrapolated 117.28 µg/mL. There were no statistically significant differences between the mean absorbance measures of HESA-A treated groups in other cell lines. Conclusion: This study showed that HESA-A doesn't fulfill the predetermined criterion of cytotoxic agents. More preclinical investigations are needed to assess the efficacy of HESA-A in cancer.
کلیدواژه‌های انگلیسی مقاله HESA-A,cytotoxicity,MTT assay,neoplastic cell lines
نویسندگان مقاله صمد muhammmadnejad | samad muhammmadnejad
cancer research center, cancer institute, tehran university of medical sciences, tehran, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

کاظم زنده دل | kazem zendehdel
cancer research center, cancer institute, tehran university of medical sciences, tehran, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

زهره مظاهری | zohreh mazaheri
vali-e-asr reproductive health research centre, tehran university of medical sciences, tehran, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

احد محمدنژاد | ahad muhammadnejad
cancer research center, cancer institute, tehran university of medical sciences, tehran, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

مهناز حدادی | mahnaz haddadi
vali-e-asr reproductive health research centre, tehran university of medical sciences, tehran, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

محمد علی محققی | mohammad ali mohagheghi
cancer research center, cancer institute, tehran university of medical sciences, tehran, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

سعید امان پور | saeid amanpour
cancer research center, cancer institute, tehran university of medical sciences, tehran, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)

نشانی اینترنتی http://bccr.tums.ac.ir/index.php/bccrj/article/view/55
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Original Articles
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات